Available Technologies - Technology Categories

All Categories > Medical > Vaccines


 Tech ID   Title    
24268 Immunogenic Peptides as Vaccines against Herpes Simplex Virus Show Detail Description
24204 Targeted Delivery of Therapeutic and Diagnostic Agents to Vimentin Show Detail Description
24198 Engineering a Novel Aluminum-Based Immune Adjuvant by Designed Synthesis of AlOOH Nanoparticles Show Detail Description
23786 Natural Adjuvant to Accelerate Vaccine Potential and Develop Immune Responses Show Detail Description
23782 Use of Polysialic Acid as an Antigen Cross-Presentation Adjuvant for Dendritic Cell Vaccines Show Detail Description
23617 Automated Chemoenzymatic Synthesis Of Glycans And Glyconconjugates Show Detail Description
23527 Heterodimer of Toll-Like Receptor Agonists for Cancer Immunotherapy Show Detail Description
23432 Identification of Major Cashew and Walnut Allergens Show Detail Description
23344 Titanium Dioxide (TiO2) Photocatalysts for Water Purification Show Detail Description
23242 Live Recombinant Tuberculosis Vaccine Show Detail Description
22936 Novel Inactivated Virus Vaccine Against Herpesviruses Show Detail Description
22892 Novel Viral Vaccine Design Methodology Show Detail Description
22847 Discovery Of Specific Human Micrornas That Induce Protection Against Influenza A Virus Infection Show Detail Description
22526 A Novel Glycopolymer to Enhance Protein Stability Show Detail Description
22413 Collaboration Opportunity: Novel Mouse Models of Human Hepatitis B Virus Infection for Drug Discovery and Vaccine Research Show Detail Description
22284 Novel, Immunogenic Epitopes for use in an HIV Vaccine Show Detail Description
22282 Novel Peptides for Development of HIV Vaccine and Therapy Show Detail Description
22262 Novel Live Recombinant Booster Vaccine Against Tuberculosis Show Detail Description
22219 Novel Group A Streptococcal Vaccine and Therapeutics Show Detail Description
21740 Outer Membrane Associated Proteins Of Leptospira Show Detail Description
21738 Molecular Cloning of Mycobacterium Tuberculosis Glutamine Synthetase (58Kd) Gene Show Detail Description
21737 Adjuvant Enhancing Immunoprotective Capacity of Extracellular Proteins Against Tuberculosis Show Detail Description
21724 Improved Immunization Strategy Using Recombinant BCG Vaccines Show Detail Description
21629 Apicoplast-Deficient, Attenuated Strains of Plasmodium for Use as Malaria Vaccines Show Detail Description
21394 Real Time Adaptive External Immune System Show Detail Description
20955 Self-Adjuvanting Viral, Bacterial, Parasitic, and Tumor Vaccines Show Detail Description
20462 Synthetic Peptide for the Vaccination of Systemic Lupus Erythematosus Show Detail Description
20456 Safe And Potent Vaccines Against Tularemia Show Detail Description
20290 Maleimide Tumor Antigen-carrier Protein Conjugates for Cancer Show Detail Description
20146 Recombinant Tuberculosis BCG Vaccine Elicits a Highly Protective Host Immune Response Show Detail Description
20145 New Recombinant Tuberculosis BCG Vaccine for Immunocompromised Patients and Others Show Detail Description
20088 GM-CSF and IL-4 Therapy for In-situ Expansion of Dendritic Cells and Enhancement of Vaccine-Based Immunity Show Detail Description
19681 Vaccination Platform for Persistent Viruses Show Detail Description
19028 NOVEL ANTIGEN TARGETS IN PROSTATE CANCER PATIENTS USEFUL FOR VACCINE DEVELOPMENT AND TREATMENT Show Detail Description
19026 HUMAN IMMUNOSTIMULATORY T CELLS Show Detail Description
19022 Methods for Enhancing the Production of Viral Vaccines in Cell Culture Show Detail Description
19010 MODULATION OF B-CELL CHEMOATTRACTANT/RECEPTOR INTERACTION AS TREATMENT FOR IMMUNE DISEASE Show Detail Description
18916 A New Process Of Adding Alkyl Groups To Organic Substrates Using TmI2(MeOCH2CH2OMe)3 Show Detail Description
18903 Her2/neu Vaccine Protects Against Tumor Growth Show Detail Description
17040 Mycobacterial sulfation pathway proteins and methods of use thereof Show Detail Description
11443 Red Blood Cell Preservation Show Detail Description
11316 High-Throughput Screening of Neuraminidase Inhibitors Show Detail Description
11214 Cryopreserving Human Tissue Show Detail Description
11173 HEV Capsid as Multivalent Immunogens or for Drug Delivery Systems Show Detail Description
10255 Antibody Fusion Proteins for Treating Cancer Show Detail Description
10174 Granulin as a Target for Tumor Diagnosis and Growth Regulation Show Detail Description
10134 A Method to Design Self-Assembling Proteins Show Detail Description
10086 Antigens For Improved Lyme Disease Vaccines And Diagnostic Reagents Show Detail Description

Back To Search

University of California
Innovation Alliances and Services

1111 Franklin Street, 5th Floor, Oakland, CA 94607-5200 | http://www.ucop.edu/ott/
Tel: 510.587.6000 | Fax: 510.587.6090 | UC.technologies@ucop.edu